| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.083 | 0.5 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |